Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Role of Endothelial Nitric Oxide Synthase Polymorphic Gene (c.894 G>T) in Coronary Artery Dilation Disease

NCT06220682 is registered in ClinicalTrials.gov with Cairo University as lead sponsor.

NCT NCT06220682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06220682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Role of Endothelial Nitric Oxide Synthase Polymorphic Gene (c.894 G>T) in Coronary Artery Dilation Disease
Lead sponsor
Cairo University
Phase
Observational
Overall status
Completed
Start date
December 1, 2020
Completion date
June 30, 2022
Enrollment
100 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

coronary artery ectasia